WHY SIMOA FOR NEUROLOGY
Measure neurological biomarkers in blood, serum, and CSF with sensitivity designed for challenging analytes and longitudinal studies.
Explore assays spanning protein pathology, neurodegeneration, neuroinflammation, synaptic biology, and multiplex biomarker panels on a single platform.
Generate reproducible measurements suitable for monitoring disease progression, treatment response, and neurobiological change over time.
EXPLORE DISEASE-SPECIFIC BIOMARKER APPLICATIONS
Neurological diseases involve multiple overlapping biological processes.
Explore biomarker strategies that investigate neuroinflammation, synaptic health, neurodegeneration, and protein pathology to address disease-specific research questions across major central nervous system indications.
Alzheimer’s Disease
Research Applications: Study relationships between tau pathology, glial activation, synaptic dysfunction, and neurodegeneration throughout disease progression.
Example Biomarker Strategy:
| Tau Pathology |
|
| Integrated AD Biology |
|
Multiple Sclerosis (MS)
Research Applications Characterize inflammatory activity, treatment response, and ongoing neuroaxonal injury.
Example Biomarker Strategy:
| Neuroaxonal Injury & Astroglial Response |
|
| Astrocyte Activation |
|
| Microglial Activity |
|
| Inflammatory Signaling |
|
Parkinson’s Disease
Research Applications: Investigate protein aggregation, neuronal dysfunction, and inflammatory processes associated with disease progression.
Example Biomarker Strategy:
| α-Synuclein Pathology |
|
| Synaptic Health & Function |
|
| Neuronal Injury and Inflammation |
|
Amyotrophic Lateral Sclerosis (ALS)
Research Applications: Investigate neurodegenerative processes and emerging biomarkers associated with disease progression.
Example Biomarker Strategy:
| Protein Pathology |
|
| Neuroaxonal Injury and Inflammation |
|
| Synaptic Dysfunction |
|
Traumatic Brain Injury (TBI)
Research Applications: Study acute injury, chronic neurobiological changes, and long-term neurological outcomes.
Example Biomarker Strategy:
| Acute Injury Characterization |
|
| Neuroinflammatory & Astroglial Response |
|
| Long-Term Neurodegeneration |
|
| Trauma-Associated Tau Biology |
|
Featured Resources
Discover Emerging Biomarkers in Alzheimer’s Disease
Stay current on novel biomarker approaches and evolving disease biology.
Featured Resource: p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research Webinar
Validate Biomarkers for Clinical and Translational Research
Learn how blood-based biomarkers are being evaluated in clinical research and translational applications.
Featured Resource: Clinical validation of the LucentAD p-Tau 217 as a lab developed test (LDT) for clinical use
Advance Therapeutic Development
Learn how blood-based biomarkers can support translational and clinical development programs.
Featured Webinar: Biomarker Strategies for Neurological Drug Development
Learn About Simoa Accelerator Laboratory Services
Discover how the Simoa® Accelerator provides end-to-end support for liquid biomarker programs.
Featured Blog: Accelerator Laboratory Services: The Biomarker Powerhouse
Accelerate Your Neurology Biomarker Research
Connect with a Quanterix expert to identify the biomarkers, assays, and research strategies best suited for your neurological disease area and study objectives.